A detailed history of Avantax Planning Partners, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 4,762 shares of BSX stock, worth $487,438. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,762
Previous 4,818 1.16%
Holding current value
$487,438
Previous $371,000 7.55%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $4,085 - $4,704
-56 Reduced 1.16%
4,762 $399,000
Q2 2024

Aug 09, 2024

SELL
$67.33 - $77.71 $6,261 - $7,227
-93 Reduced 1.89%
4,818 $371,000
Q1 2024

May 02, 2024

BUY
$57.6 - $68.62 $282,873 - $336,992
4,911 New
4,911 $336,000
Q1 2020

Apr 27, 2020

SELL
$25.83 - $45.71 $138,035 - $244,274
-5,344 Closed
0 $0
Q4 2019

Jan 15, 2020

SELL
$37.87 - $45.37 $6,702 - $8,030
-177 Reduced 3.21%
5,344 $242,000
Q3 2019

Nov 08, 2019

BUY
$40.31 - $43.45 $3,224 - $3,476
80 Added 1.47%
5,521 $225,000
Q2 2019

Aug 07, 2019

BUY
$34.91 - $42.98 $1,326 - $1,633
38 Added 0.7%
5,441 $232,000
Q1 2019

May 08, 2019

BUY
$32.91 - $40.75 $111,992 - $138,672
3,403 Added 170.15%
5,403 $207,000
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $90,367 - $111,185
-2,848 Reduced 58.75%
2,000 $71,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $38.63 $159,159 - $187,278
4,848 New
4,848 $187,000
Q2 2018

Aug 13, 2018

SELL
$26.84 - $34.32 $191,127 - $244,392
-7,121 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $179,449 - $203,233
7,121 New
7,121 $197,000
Q4 2017

Feb 09, 2018

SELL
$24.79 - $29.8 $174,620 - $209,911
-7,044 Closed
0 $0
Q3 2017

Oct 19, 2017

BUY
$26.26 - $29.17 $184,975 - $205,473
7,044
7,044 $205,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.